Health CareHealth Care Equipment & Services
  • Price (USD)113.32
  • Today's Change-2.66 / -2.29%
  • Shares traded1.13m
  • 1 Year change-10.90%
  • Beta1.1985
Data delayed at least 15 minutes, as of Sep 21 2017 20:12 BST.
More ▼

Events & Activity

  • ZBH:NYQ ex-dividend date 21 Sep 2017 for next dividend payment
  • ZBH:NYQ price moved over +1.01% to 116.65
  • ZBH:NYQ trading volume exceeds daily average by +15.02%
  • ZBH:NYQ price falls below 15-day moving average to 115.33 at 10:34 BST

Key statistics

As of last trade, Zimmer Biomet Holdings Inc (ZBH:NYQ) traded at 113.32, 18.50% above the 52 week low of 95.63 set on Nov 14, 2016.
52-week range
95.63Nov 14 2016133.49Jul 17 2017
Markit short selling activity
Previous close115.98
Average volume1.26m
Shares outstanding202.20m
Free float201.81m
P/E (TTM)33.16
Market cap23.50bn USD
EPS (TTM)3.50
Annual div (ADY)0.96
Annual div yield (ADY)0.83%
Div ex-dateSep 21 2017
Div pay-dateOct 27 2017
Data delayed at least 15 minutes, as of Sep 21 2017 20:12 BST.
More ▼
© Thomson Reuters Click for restrictions
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.